课题基金 / 基金详情

SCALE UP SYNTHESIS TECHNOLOGY FOR ANTICANCER DRUGS

SCALE UP SYNTHESIS TECHNOLOGY FOR ANTICANCER DRUGS
抗癌药物的放大合成技术
批准号:
2774053
负责人:
Alex G Bonner
金额:
$24.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-01 至 2000-02-29

项目摘要

项目成果

Alex G Bonner的其他基金

相似基金

相关文献

中文摘要
翻译
主要目标是开发有效的合成技术 千克量的寡核苷酸和其他潜在的抗癌药物 化合物。次要目标是将技术应用到开发中 抗癌抗艾滋病小分子组合文库的研究进展 药物筛查。具体研究目标为:(1)完成开发 和分期设计的自动合成装置的构建 1、(2)选择高负荷、高效率的固体支撑基质, 优化合成化学;(3)集成自动化原位合成子 形成/激活和DNA合成;(4)实现可重复性98-99% 10-100g规模的逐步合成效率;(5)发展 流程规模的分离和提纯方案; (6)合成10-100g用量的几种潜在抗癌药物 药用级的;(7)进行体外生物试验 有效性和毒性,并与由 当前方法;(8)显示出显著的效率改进和 与目前的方法相比成本降低;(9)将该系统应用于 小分子(<700 mW)组合库混合物的合成 含有浓度大于100微米的成分;和(10) 对库混合物进行化学分析以确认其 适用于基于细胞和体外药物筛选的应用。更多 高效经济的规模化合成技术 寡核苷酸、抗癌药物和组合文库将 促进新的治疗药物的识别和评估。 拟议的商业应用:该项目将扩大规模 反义寡核苷酸等的合成技术 用于开发和临床试验的化合物,以千克计 抗癌抗癌新药的研制 爱滋病申请。这项技术的推广到……的发展 组合文库将加速识别新的 潜在的药物制剂通过使非常大量的 高效、经济高效地生产不同的材料 生物活性筛选计划。
英文摘要
The primary objective is to develop efficient technology for synthesis of kilogram amounts of oligonucleotides and other potential anticancer compounds. A secondary goal is to apply the technology to the development of small-molecule combinatorial libraries for anticancer and anti-AIDS drug screening. Specific research aims are: (1) completing development and construction of the automated synthesis instrument designed in Phase 1; (2) selecting a high-load, high-efficiency solid-support matrix and optimizing synthetic chemistry; (3) integrating automated in situ synthon formation/activation and DNA synthesis; (4) achieving reproducible 98-99% stepwise synthesis efficiency at the 10-100g scale; (5) developing process-scale isolation and purification protocols; (6) synthesizing 10-100g amounts of several potential anticancer agents of pharmaceutical- grade; (7) performing in vitro biological testing for efficacy and toxicity, and for comparison to compounds produced by current methods; (8) demonstrating significant efficiency improvement and cost-reduction compared to current methods; (9) applying the system to the synthesis of small-molecule (<700 MW) combinatorial library mixtures containing components at concentrations greater than 100muM; and (10) performing chemical analysis of the library mixtures to confirm their suitability for cell-based and in vitro drug screening applications. More efficient and economical technology for scale-up synthesis of oligonucleotides, anticancer agents and combinatorial libraries will facilitate the identification and evaluation of new therapeutic agents. PROPOSED COMMERCIAL APPLICATION: The project will develop scale-up technology for synthesizing antisense oligonucleotides and other compounds in kilogram amounts for use in the development, clinical trials and manufacture of new pharmaceutical products with anticancer and anti- AIDS applications. The extension of the technology to the development of combinatorial libraries will accelerate the identification of new potential pharmaceutical agents by enabling very large numbers of different materials to be produced efficiently and cost-effectively for biological activity screening programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monolithic Media and Technology for Bioprocessing
  • 批准号:
    8196593
  • 项目类别:
  • 资助金额:
    $14.6万
  • 财政年份:
    2011
  • 负责人:
    Alex G Bonner
  • 依托单位:
Ultrafiltration Device for Rapid, High, Through-put Sample Preparation
  • 批准号:
    7214987
  • 项目类别:
  • 资助金额:
    $14.98万
  • 财政年份:
    2007
  • 负责人:
    Alex G Bonner
  • 依托单位:
Novel Chromatographic Sorbents for Large Biomolecules
  • 批准号:
    6834521
  • 项目类别:
  • 资助金额:
    $14.06万
  • 财政年份:
    2004
  • 负责人:
    Alex G Bonner
  • 依托单位:
Novel Chromatographic Sorbents for Large Biomolecules
  • 批准号:
    7224893
  • 项目类别:
  • 资助金额:
    $44.14万
  • 财政年份:
    2004
  • 负责人:
    Alex G Bonner
  • 依托单位:
海外基金